Info on the dilution and adulteration of copyright will not be routinely collected in Europe. Nevertheless, based on complementary facts reported on the EMCDDA and knowledge out there from other sources, some Investigation of new trends about pharmacologically active adulterants in copyright solutions in Europe might be carried out. Many thanks